Cargando…
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
An incomplete view of the mechanisms that drive metastasis, the primary cause of cancer-related death, has been a major barrier to development of effective therapeutics and prognostic diagnostics. Increasing evidence indicates that the interplay between microenvironment, genetic lesions, and cellula...
Autores principales: | Rambow, Florian, Marine, Jean-Christophe, Goding, Colin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771388/ https://www.ncbi.nlm.nih.gov/pubmed/31575676 http://dx.doi.org/10.1101/gad.329771.119 |
Ejemplares similares
-
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
por: Falletta, Paola, et al.
Publicado: (2017) -
Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
por: Falletta, Paola, et al.
Publicado: (2022) -
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
por: Najem, Ahmad, et al.
Publicado: (2021) -
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
por: Gautron, Arthur, et al.
Publicado: (2021) -
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
por: Micevic, Goran, et al.
Publicado: (2017)